Featured Research

from universities, journals, and other organizations

Vaccine Triggers Immune System To Attack Cancerous Tumors

Date:
August 14, 1998
Source:
University Of Michigan
Summary:
Using a vaccine made from specialized white blood cells called dendritic cells spiked with cancer proteins, University of Michigan scientists have found a way to activate the immune system to attack malignant tumors and prevent the development of new tumors in mice.

ANN ARBOR---Using a vaccine made from specialized white blood cells called dendritic cells spiked with cancer proteins, University of Michigan scientists have found a way to activate the immune system to attack malignant tumors and prevent the development of new tumors in mice.

"Immunization with the dendritic cell vaccine was effective against two types of solid tumors---sarcomas and breast carcinomas---in two unrelated strains of mice," said James J. Mulé, professor of surgery in the U-M Medical School and director of the Tumor Immunotherapy Program in the U-M Health System's Comprehensive Cancer Center. "Based on these encouraging results, we have begun a Phase I clinical trial in pediatric and adult patients with advanced solid tumors."

Results of the study were published in the Aug. 4 issue of the Proceedings of the National Academy of Sciences. Ryan C. Fields, from Bloomfield Hills, Mich., who received his U-M undergraduate degree in May 1998, and Koichi Shimizu, M.D., U-M research fellow, are joint first authors on the study.

Fields, Shimizu and Mulé used immature dendritic cells from mouse bone marrow as the basis for their vaccine. Dendritic cells are specialized white blood cells whose job it is to alert the immune system to the presence of invading cancers, bacteria or viruses, so the invaders can be surrounded and destroyed. When they find cancer cells, dendritic cells sound the alert by displaying pieces of tumor proteins called antigens on long projections extending from the center of the dendritic cell.

Like Cinderella's prince searching for a woman who matches the glass slipper, the dendritic cell presents these antigens to other white blood cells called T-lymphocytes until it finds those with receptors that fit the tumor antigen. Once a match is made, T-lymphocytes produce messenger chemicals which stimulate production of a flood of T-lymphocyte "clones," all equipped with the exact receptor needed to attack and destroy one specific type of tumor cell.

"Cancer cells often hide from lymphocytes by becoming invisible," Fields explained. "Instead of displaying foreign proteins on the surface of tumor cells, most remain inside the cell where the immune system cannot detect them. Dendritic cells bring these hidden antigens out of hiding triggering this intense immune system response."

While other researchers are experimenting with tumor vaccines made from single tumor peptides mixed with dendritic cells, Mulé and his colleagues were the first to use whole tumors called lysates---tumor cells which have been frozen and thawed several times to kill them. "By using the entire tumor cell, we are sensitizing the immune system to attack all the antigens in that tumor, rather than just one or two," said Mulé. "A broader immune response makes it less likely that tumor cells will escape detection."

Significant results from the U-M study include:

¤ When Fields and Shimizu mixed mouse dendritic cells fed with sarcoma tumor lysates with T-lymphocytes in a test tube, they generated a flood of new T-lymphocytes primed to kill the sarcoma. When live sarcoma cells were added to the mixture, T-lymphocytes killed 70 percent of the sarcoma cells within four hours.

¤ Mice vaccinated with the sarcoma-specific dendritic cell vaccine and then given a lethal dose of live sarcoma cells remained tumor free for at least 100 days.

¤ Mice with secondary tumors in their lungs had a 90 percent reduction in lung metastases after dendritic cell vaccination.

¤ When CD8 T-lymphocytes were removed from the immunized animal, the dendritic cell vaccine lost its therapeutic effect. When CD4 T-lymphocytes were removed, the effect was greatly diminished.

U-M scientists use immature dendritic cells fresh from the bone marrow's production factory, rather than mature dendritic cells which have already circulated through the lymphatic system to other organs. "At this early undifferentiated stage of development, it is easier to sensitize them to react to an individual's specific cancer antigens," Mulé explained.

The research was supported by the National Cancer Institute/National Institutes of Health, the U.S. Army Research Office and by gifts from C.J. and E.C. Aschauer and Abbott Laboratories to the U-M's Department of Surgery and the Tumor Immunotherapy Program.


Story Source:

The above story is based on materials provided by University Of Michigan. Note: Materials may be edited for content and length.


Cite This Page:

University Of Michigan. "Vaccine Triggers Immune System To Attack Cancerous Tumors." ScienceDaily. ScienceDaily, 14 August 1998. <www.sciencedaily.com/releases/1998/08/980814064357.htm>.
University Of Michigan. (1998, August 14). Vaccine Triggers Immune System To Attack Cancerous Tumors. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/1998/08/980814064357.htm
University Of Michigan. "Vaccine Triggers Immune System To Attack Cancerous Tumors." ScienceDaily. www.sciencedaily.com/releases/1998/08/980814064357.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) — The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) — Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) — A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) — The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins